skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

9 Total results for product and free and sample content found

Datamonitor Healthcare, Pink Sheet, Scrip, Me...

Pharma Intelligence Podcasts

28 Jan 2021

Pharma Intelligence Podcasts

Listen to the Pharma Intelligence podcasts on Spotify, Apple Podcasts, Soundcloud and Alexa

Topic Coronavirus Manufacturing Market Intelligence Clinical Trials Blog Clinical Trials Drug Pricing

Generics Bulletin

European Industry Played Key Role In Mitigating COVID-19

By David Wallace 27 Nov 2020

Generics Bulletin Accord James Burt

In the first part of an exclusive two-part interview, James Burt – Accord’s executive vice-president for Europe, the Middle East and North Africa – talks to Generics Bulletin about the key actions taken by the generics industry to mitigate the coronavirus pandemic, and the changed landscape that the off-patent arena can expect to see in future.

Topic Coronavirus Manufacturing

Pink Sheet

Coronavirus Supply Chain Threats Demand Coordinated Industry Response

By Bowman Cox 27 Nov 2020

Emergency Agency Meeting

Just as they did during the heparin crisis a decade ago, pharmaceutical companies must coordinate on coronavirus, Rx-360 CEO says.

Topic Manufacturing Vaccines Coronavirus


Coronavirus Update: Moderna And Pfizer Respond To Vaccine Trial Transparency Demands

By Scrip Team 25 Sep 2020

Covid19 Testing

Moderna led by releasing the trial protocol for its COVID-19 vaccine study, followed by Pfizer, as industry faces demands for transparency.

Topic Coronavirus Manufacturing Clinical Trials

Pink Sheet

Global Supply Chain Security Meets US Presidential Politics

By Michael McCaughan 21 Sep 2020

Trump Biden US Elections

Joe Biden’s presidential campaign now has a plan to address supply chains and encourage US-based manufacturing of prescription drugs. That affirms the unlikely national prominence of the issue – and reduces the chances of meaningful legislation this year.

Topic US Election 2020 Manufacturing

Pink Sheet

US Researchers Working Toward Universal Coronavirus Vaccine

By Sue Sutter 18 Feb 2020

Coronavirus Vaccine

The SARS-CoV-2 outbreak has the federal government working not only on a vaccine candidate specifically targeted at the novel coronavirus but also thinking more broadly about ways to head off future potential pandemics with emerging pathogens.

Pink Sheet

UK Firms Asked To Check Coronavirus Supply Chain Impact

By Ian Schofield 18 Feb 2020


Authorities Also Investing In Vaccines And Tests Amid concerns that the coronavirus outbreak could have an impact on the supply of APIs and other materials sourced from Chinese manufacturers, pharmaceutical companies are to assess their supply chain situation to help ensure patients do not experience medicine shortages.

Generics Bulletin

Celltrion Sets Out Strategy For China

By David Wallace 27 Jan 2020


Celltrion has unveiled plans to construct a biologics plant in Wuhan, China, as well as setting up a direct sales network in the country, as part of its wider global strategy that also involves launching a new biosimilar every year to 2030.

In Vivo

Outlook 2020 Report

18 Dec 2019


Tap Outlook 2020’s essential coverage of medtech, R&D, clinical trials and regulation, manufacturing, and more with your extract from our most powerful report.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: